Gene · 427
Papers1,873
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,873
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging Roles of Ceramides in Breast Cancer Biology and Therapy. | Int J Mol Sci | 2022 | 36232480 | PubTator, text mining | PubMed |
| Metabolomics in Diabetic Retinopathy: From Potential Biomarkers to Molecular Basis of Oxidative Stress. | Cells | 2022 | 36230967 | PubTator, text mining | PubMed |
| Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer. | Cancers (Basel) | 2022 | 36230781 | PubTator, text mining | PubMed |
| Exploring the mechanism of Buyang Huanwu Decoction in the treatment of spinal cord injury based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36221378 | PubTator, text mining | PubMed |
| Ex vivo exposures to arsenite and its methylated trivalent metabolites alter gene transcription in mouse sperm cells. | Toxicol Appl Pharmacol | 2022 | 36209798 | PubTator, text mining | PubMed |
| Deficiency of the frontotemporal dementia gene GRN results in gangliosidosis. | Nat Commun | 2022 | 36207292 | PubTator, text mining | PubMed |
| Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology. | NPJ Parkinsons Dis | 2022 | 36202848 | PubTator, text mining | PubMed |
| Inhibition of inflammasome activation via sphingolipid pathway in acute lung injury by Huanglian Jiedu decoction: An integrative pharmacology approach. | Phytomedicine | 2022 | 36202056 | PubTator, text mining | PubMed |
| Late isocaloric eating increases hunger, decreases energy expenditure, and modifies metabolic pathways in adults with overweight and obesity. | Cell Metab | 2022 | 36198293 | PubTator, text mining | PubMed |
| Network Pharmacology and Molecular Docking to Explore the Mechanism of Kangxian Decoction for Epilepsy. | Evid Based Complement Alternat Med | 2022 | 36193133 | PubTator, text mining | PubMed |
| Identification of a novel lipid metabolism-related gene signature for predicting colorectal cancer survival. | Front Genet | 2022 | 36147494 | PubTator, text mining | PubMed |
| Targeting Ceramides and Adiponectin Receptors in the Islet of Langerhans for Treating Diabetes. | Molecules | 2022 | 36144859 | PubTator, text mining | PubMed |
| The Role of Sphingomyelin and Ceramide in Motor Neuron Diseases. | J Pers Med | 2022 | 36143200 | PubTator, text mining | PubMed |
| Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells. | Cancers (Basel) | 2022 | 36139656 | PubTator, text mining | PubMed |
| The Landscape of Cell Death Processes with Associated Immunogenic and Fibrogenic Effects in Arrhythmogenic Cardiomyopathy. | J Cardiovasc Dev Dis | 2022 | 36135446 | PubTator, text mining | PubMed |
| Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity. | Mol Neurodegener | 2022 | 36131294 | PubTator, text mining | PubMed |
| Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer. | Front Oncol | 2022 | 36119530 | PubTator, text mining | PubMed |
| Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease. | Neurobiol Dis | 2022 | 36113749 | PubTator, text mining | PubMed |
| Brain lipidomics: From functional landscape to clinical significance. | Sci Adv | 2022 | 36112688 | PubTator, text mining | PubMed |
| Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia. | FASEB J | 2022 | 36106439 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/427/papers?page=18